Cochlear Limited
(ASX:COH) shares have posted their biggest decline in more than two years after its FY 2015 profit result disappointed.
The global biotech announced a net profit of $145.8m for the year ended June 30, a 56 per cent increase on the previous year.
But the figure fell short of analyst expectations, the consensus forecasting about $156.9m.
The company sold almost 27,000 of its hearing implants over the past financial year, up 3 per cent on 2014.
Cochlear will pay a final fully-franked dividend of $1, bringing the year's total distribution to $1.90.
